Mosaic ImmunoEngineering, Inc. Stock
Stocks
CPMV
US61945M1018
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
10:38:13 2026-04-20 EDT
|
5-day change | 1st Jan Change | ||
| 0.3280 USD | -.--% |
|
+446.67% | +5.47% |
| Market Cap | 616K 561K 517K 470K 883K 57.07M 928K 6.3M 2.5M 31.17M 2.31M 2.26M 97.83M | P/E 2024 |
-5.39x | P/E 2025 | -3.11x |
|---|---|---|---|---|---|
| Enterprise Value | 2.28M 2.08M 1.91M 1.74M 3.26M 211M 3.43M 23.27M 9.25M 115M 8.55M 8.37M 362M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
11.32% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | +446.67% | ||
| Current month | +139.77% | ||
| 1 month | -1.50% | ||
| 3 months | +437.70% | ||
| 6 months | -52.79% | ||
| Current year | +5.47% |
| 1 week | 0.08 | 0.33 | |
| 1 month | 0.06 | 0.33 | |
| Current year | 0.05 | 0.75 | |
| 1 year | 0.05 | 0.75 | |
| 3 years | 0.05 | 1.13 | |
| 5 years | 0.05 | 3 | |
| 10 years | 0.05 | 9.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Steven King
CEO | Chief Executive Officer | 61 | 2020-08-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Steven King
BRD | Director/Board Member | 61 | 2020-08-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/18/22 | Others | Founder | 0 | 0.0000% | ||
| 2/18/22 | Others | Chief Executive Officer | 0 | 0.0000% | ||
| 2/18/22 | Others | Director | 0 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +446.67% | -45.33% | -34.53% | 616K | ||
| -2.49% | -3.76% | +50.31% | +62.10% | 63.66B | ||
| -0.63% | -2.91% | +6.20% | +89.22% | 58.56B | ||
| -2.37% | -2.22% | +22.87% | +82.31% | 54.19B | ||
| -2.19% | -6.15% | +11.92% | +108.08% | 44.66B | ||
| -1.89% | -7.28% | +13.22% | +19.74% | 40.51B | ||
| -0.93% | -0.47% | +19.73% | +43.75% | 36.27B | ||
| +1.11% | -6.44% | +130.68% | +641.83% | 34.89B | ||
| -0.80% | +0.61% | +77.26% | +56.26% | 32.26B | ||
| -2.17% | +16.65% | -29.21% | +474.05% | 31.01B | ||
| Average | -1.24% | -1.09% | +25.77% | +154.28% | 40B | |
| Weighted average by Cap. | -1.48% | -1.85% | +32.16% | +150.90% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -922K -840K -774K -704K -1.32M -85.38M -1.39M -9.42M -3.74M -46.63M -3.46M -3.39M -146M | -688K -626K -577K -525K -985K -63.69M -1.04M -7.03M -2.79M -34.79M -2.58M -2.53M -109M |
| Net Debt | 1.48M 1.35M 1.24M 1.13M 2.12M 137M 2.22M 15.09M 6M 74.73M 5.54M 5.43M 235M | 1.66M 1.51M 1.4M 1.27M 2.38M 154M 2.5M 16.98M 6.75M 84.07M 6.24M 6.11M 264M |
Employees
5
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-20 | US$0.0851 | +11.97% | 12,041 |
| 26-11-17 | US$0.0760 | +26.67% | 108 |
- Stock Market
- Stocks
- CPMV Stock
Select your edition
All financial news and data tailored to specific country editions
















